Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J.
Catalent helps solve clinical trial challenges by reliably supplying studies of all sizes and complexities. Catalent’s commitment to quality and service excellence is evident in its innovative flexible solutions, modern global facilities, and 25+ years’ experience in supply chain management across 5,000+ studies in more than 80 countries.